S&P 500   3,344.94 (-0.84%)
DOW   29,011.87 (-0.71%)
QQQ   231.96 (-1.20%)
AAPL   316.88 (-1.07%)
FB   211.33 (-1.51%)
GOOGL   1,499.78 (-1.13%)
AMZN   2,118.55 (-1.60%)
NVDA   298.72 (-3.23%)
BABA   214.00 (-1.85%)
MU   57.22 (-3.02%)
GE   12.33 (-1.60%)
AMD   55.28 (-3.47%)
T   38.52 (-0.23%)
ACB   1.66 (-1.19%)
F   7.95 (-1.00%)
NFLX   384.06 (-0.50%)
BAC   34.32 (-1.52%)
DIS   139.31 (-0.76%)
GILD   69.08 (+3.10%)
S&P 500   3,344.94 (-0.84%)
DOW   29,011.87 (-0.71%)
QQQ   231.96 (-1.20%)
AAPL   316.88 (-1.07%)
FB   211.33 (-1.51%)
GOOGL   1,499.78 (-1.13%)
AMZN   2,118.55 (-1.60%)
NVDA   298.72 (-3.23%)
BABA   214.00 (-1.85%)
MU   57.22 (-3.02%)
GE   12.33 (-1.60%)
AMD   55.28 (-3.47%)
T   38.52 (-0.23%)
ACB   1.66 (-1.19%)
F   7.95 (-1.00%)
NFLX   384.06 (-0.50%)
BAC   34.32 (-1.52%)
DIS   139.31 (-0.76%)
GILD   69.08 (+3.10%)
S&P 500   3,344.94 (-0.84%)
DOW   29,011.87 (-0.71%)
QQQ   231.96 (-1.20%)
AAPL   316.88 (-1.07%)
FB   211.33 (-1.51%)
GOOGL   1,499.78 (-1.13%)
AMZN   2,118.55 (-1.60%)
NVDA   298.72 (-3.23%)
BABA   214.00 (-1.85%)
MU   57.22 (-3.02%)
GE   12.33 (-1.60%)
AMD   55.28 (-3.47%)
T   38.52 (-0.23%)
ACB   1.66 (-1.19%)
F   7.95 (-1.00%)
NFLX   384.06 (-0.50%)
BAC   34.32 (-1.52%)
DIS   139.31 (-0.76%)
GILD   69.08 (+3.10%)
S&P 500   3,344.94 (-0.84%)
DOW   29,011.87 (-0.71%)
QQQ   231.96 (-1.20%)
AAPL   316.88 (-1.07%)
FB   211.33 (-1.51%)
GOOGL   1,499.78 (-1.13%)
AMZN   2,118.55 (-1.60%)
NVDA   298.72 (-3.23%)
BABA   214.00 (-1.85%)
MU   57.22 (-3.02%)
GE   12.33 (-1.60%)
AMD   55.28 (-3.47%)
T   38.52 (-0.23%)
ACB   1.66 (-1.19%)
F   7.95 (-1.00%)
NFLX   384.06 (-0.50%)
BAC   34.32 (-1.52%)
DIS   139.31 (-0.76%)
GILD   69.08 (+3.10%)
Log in

OTCMKTS:MPHMF - Callitas Health Stock Price, Forecast & News

$0.11
0.00 (0.00 %)
(As of 02/21/2020 11:34 AM ET)
Add
Compare
Today's Range
$0.11
Now: $0.11▼
$0.11
50-Day Range
$0.00
MA: $0.03▼
$0.08
52-Week Range
$0.00
Now: $0.11▼
$0.15
Volume8,500 shs
Average Volume600 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta0.26
Callitas Health, Inc is a clinical stage company. It engages in the development of technologies for obesity, weight management, and female health and wellness. The company focuses on developing technologies for weight management, female sexual health and wellness, cannabis delivery technologies and other proprietary drugs. It launched product ToConceive in North America. Read More…

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Crude petroleum & natural gas
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MPHMF
Previous Symbol
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive MPHMF News and Ratings via Email

Sign-up to receive the latest news and ratings for MPHMF and its competitors with MarketBeat's FREE daily newsletter.

OTC:MPHMF Rates by TradingView

Callitas Health (OTCMKTS:MPHMF) Frequently Asked Questions

What is Callitas Health's stock symbol?

Callitas Health trades on the OTCMKTS under the ticker symbol "MPHMF."

Has Callitas Health been receiving favorable news coverage?

News coverage about MPHMF stock has trended negative this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Callitas Health earned a news impact score of -2.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Callitas Health.

Who are some of Callitas Health's key competitors?

What other stocks do shareholders of Callitas Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Callitas Health investors own include Sangamo Therapeutics (SGMO), Kirkland Lake Gold (KLG), Stornoway Diamond (SWY), Polymet Mining (POM), Aurora Cannabis (ACB), Insperity (NSP), Solaredge Technologies (SEDG), Incyte (INCY), Gilead Sciences (GILD) and BioCryst Pharmaceuticals (BCRX).

Who are Callitas Health's key executives?

Callitas Health's management team includes the folowing people:
  • James M. Thompson, President, Chief Executive & Operating Officer
  • Gary Stephens, Chief Financial Officer
  • Joshua Maurice, Vice President-Sales & Business Development

How do I buy shares of Callitas Health?

Shares of MPHMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Callitas Health's stock price today?

One share of MPHMF stock can currently be purchased for approximately $0.11.


MarketBeat Community Rating for Callitas Health (OTCMKTS MPHMF)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  79 (Thanks for Voting!)
Underperform Votes:  99 (Thanks for Voting!)
Total Votes:  178
MarketBeat's community ratings are surveys of what our community members think about Callitas Health and other stocks. Vote "Outperform" if you believe MPHMF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MPHMF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Featured Article: How to Invest in an Index Fund
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel